Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Joshua J. Field, MD MS, Elaine M. Majerus, MD PhD, Ken I. Ataga, MD, Elliott P. Vichinsky, MD, Cheryl Eaton, Rosemary Mazanet, MD PhD, David G. Nathan, MD

Blood (2015) 126 (23): 2178.

https://doi.org/10.1182/blood.V126.23.2178.2178

Published: 2015

Journal Articles

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

Nicoletta Machin, MD, Margaret V. Ragni, MD MPH, Lynn M. Malec, MD, Donald Brambilla, PhD, Thomas Coyle, MD, Joanna A. Davis, MD, Annette Drygalski, Andra H James, MD MPH, Shawn M Jobe, MD PhD, Barbara A. Konkle, MD, Peter Kouides, MD, Philip Kuriakose, MD, Alice D. Ma, MD, Elaine M. Majerus, MD PhD, Danielle Nance, MD, Anne T. Neff, MD, Claire S. Philipp, MD, Tzu-Fei Wang, MD, Hassan M. Yaish, MD

Blood (2015) 126 (23): 4694.

https://doi.org/10.1182/blood.V126.23.4694.4694

Published: 2015

Journal Articles

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Elaine M. Majerus, MD PhD, Kenneth I. Ataga, MD, Elliott Vichinsky, MD, Cheryl A. Eaton, BA, Rosemary Mazanet, MD PhD, David G. Nathan, MD, Joshua J. Field, MD MS

Blood (2014) 124 (21): 2718.

https://doi.org/10.1182/blood.V124.21.2718.2718

Published: 2014

Journal Articles

Interaction of ADAMTS13 with the Endothelial Cell Surface.

Anthony Vomund, PhD, Elaine M. Majerus, MD, PhD

Blood (2007) 110 (11): 3710.

https://doi.org/10.1182/blood.V110.11.3710.3710

Published: 2007

Journal Articles

A Small Fragment of ADAMTS13 Enhances Cleavage of von Willebrand Factor by the Intact Enzyme.

Elaine M. Majerus, MD, PhD

Blood (2007) 110 (11): 1742.

https://doi.org/10.1182/blood.V110.11.1742.1742

Published: 2007

Journal Articles

A C-Terminal Exosite of von Willebrand Factor Domain A2 Interacts with ADAMTS13 Spacer Domain To Accelerate Substrate Cleavage.

Weiqiang Gao, MD, PhD, Patricia J. Anderson, PhD, Elaine M. Majerus, MD, PhD, Elodee A. Tuley, J. Evan Sadler, MD, PhD

Blood (2006) 108 (11): 1785.

https://doi.org/10.1182/blood.V108.11.1785.1785

Published: 2006

Journal Articles

Characterization of the Binding Interaction between ADAMTS13 and von Willebrand Factor (VWF).

Elaine M. Majerus, MD, PhD, Patricia J. Anderson, PhD, J. Evan Sadler, MD, PhD

Blood (2004) 104 (11): 515.

https://doi.org/10.1182/blood.V104.11.515.515

Published: 2004

NARROW

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Interaction of ADAMTS13 with the Endothelial Cell Surface.

A Small Fragment of ADAMTS13 Enhances Cleavage of von Willebrand Factor by the Intact Enzyme.

A C-Terminal Exosite of von Willebrand Factor Domain A2 Interacts with ADAMTS13 Spacer Domain To Accelerate Substrate Cleavage.

Characterization of the Binding Interaction between ADAMTS13 and von Willebrand Factor (VWF).

Email alerts

ASH Publications

American Society of Hematology

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Interaction of ADAMTS13 with the Endothelial Cell Surface.

A Small Fragment of ADAMTS13 Enhances Cleavage of von Willebrand Factor by the Intact Enzyme.

A C-Terminal Exosite of von Willebrand Factor Domain A2 Interacts with ADAMTS13 Spacer Domain To Accelerate Substrate Cleavage.

Characterization of the Binding Interaction between ADAMTS13 and von Willebrand Factor (VWF).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only